BALDACCI, Erminia
 Distribuzione geografica
Continente #
NA - Nord America 1.167
EU - Europa 416
AS - Asia 335
AF - Africa 11
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.939
Nazione #
US - Stati Uniti d'America 1.148
SG - Singapore 157
IT - Italia 130
SE - Svezia 116
CN - Cina 83
IN - India 71
DE - Germania 34
RO - Romania 26
BG - Bulgaria 22
CA - Canada 13
AT - Austria 12
BE - Belgio 11
UA - Ucraina 11
FI - Finlandia 10
RU - Federazione Russa 10
IE - Irlanda 8
ID - Indonesia 7
TG - Togo 7
GB - Regno Unito 6
ES - Italia 5
MX - Messico 5
VN - Vietnam 5
PL - Polonia 4
AR - Argentina 3
AU - Australia 3
ZA - Sudafrica 3
FR - Francia 2
LV - Lettonia 2
NL - Olanda 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
KW - Kuwait 1
LT - Lituania 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
Totale 1.939
Città #
Chandler 141
Fairfield 136
Singapore 125
Ashburn 80
Santa Clara 75
Wilmington 58
San Paolo di Civitate 57
Woodbridge 55
Beijing 53
Cambridge 50
Seattle 46
Houston 42
Princeton 42
Millbury 36
Rome 33
Lawrence 31
Plano 30
Sofia 22
Bremen 17
Andover 14
Ann Arbor 14
San Diego 13
Brussels 11
Norwalk 9
Vienna 9
Dublin 7
Falkenstein 7
Jakarta 7
Lomé 7
Moscow 7
Boston 6
Milan 6
Toronto 6
Ottawa 5
Ho Chi Minh City 4
New York 4
Redwood City 4
Buffalo 3
Fremont 3
Jacksonville 3
Los Angeles 3
Madrid 3
Muizenberg 3
Sirmione 3
Catania 2
Dearborn 2
Federal 2
Helsinki 2
Mannheim 2
Monterotondo 2
Monterrey 2
Phoenix 2
Reggio Nell'emilia 2
Riga 2
Stockholm 2
Sydney 2
Amman 1
Arnsberg 1
Atlanta 1
Baku 1
Barcelona 1
Bern 1
Bratislava 1
Brescia 1
Brisbane 1
Buenos Aires 1
Bühl 1
Chicago 1
Cork 1
Costa Mesa 1
Delhi 1
Frankfurt am Main 1
Gurgaon 1
Hefei 1
Jamaica 1
Kunming 1
Kuwait 1
Lambeth 1
Lappeenranta 1
Lodz 1
London 1
Manila 1
Mexico 1
Mexico City 1
Mission 1
Montreal 1
Nanjing 1
Nicosia 1
Redmond 1
Richardson 1
Romainville 1
Salt Lake City 1
San Mateo 1
Shenyang 1
Simi Valley 1
Stansted 1
Stolberg 1
Tauranga 1
Tel Aviv 1
Trumbull 1
Totale 1.358
Nome #
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma 102
Plasma vitamin K1 levels in Italian patients receiving oral anticoagulant therapy for mechanical heart prosthesis: a case-control study 83
null 69
Direct oral anticoagulants in patients affected by major congenital thrombophilia 69
Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: A single-center experience 64
Oral anticoagulant therapy in Italian patients 80 yr of age or older with atrial fibrillation: a pilot study of low vs. standard PT/INR targets. 63
Acquired FXIII deficiency and AL amyloidosis: A case of a rare association 63
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case. 63
Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety. 60
A Case Of Thrombosis In Congenital Afibrinogenemia: A Physiopathologic And Management Dilemma 58
Application of Global Coagulation Assays in Hemophilia B Patients to Evaluate the Hemostatic Potential in Baseline Conditions 53
Application of global coagulation assays in Hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 52
Application of global coagulation assays in hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 51
Direct oral anticoagulants for the treatment of Mondor's disease not responding to low-molecular weight heparin 50
COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome 50
Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants 49
A case of thrombosis in congenital afibrinogenemia patient: a physiopathologic and management dilemma 48
Retrospective Evaluation of Phenotype and Management of A-hypo-dys-Fibrinogenemia in a Cohort of Italian Patients 46
Investigation of Possible Correlation Between Clinical and Laboratory Phenotype in Congenital FXI Deficiency: Results from a Single Center 43
RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS 41
Investigation of possible correlation between clinical and laboratory phenotype in congenital FXI deficiency: results from a single center 40
null 39
Right elbow arthropathy in a patient with severe haemophilia A 39
Dental invasive procedures in von Willebrand disease outpatients treated with high purity FVIII/VWF complex concentrate (Fanhdi®): experience of a single center 39
Congenital FXI deficiency: preliminary results of phenotypic (clinical and laboratory) and genotypic characterization of a case series from a single center 38
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome 38
null 37
USE OF ANAGRELIDE IN A COHORT OF PATIENTS FROM THE LAZIO REGION: COMPARISON WITH RECOMMENDATIONS FROM THE ITALIAN GUIDELINES 36
Dental invasive procedures in von willebrand disease (VWD) outpatients treated with high purity VWF/FVIII complex concentrate: experience of a single center 35
Investigation of possible correlation between clinical and laboratory phenotype in congenital FXI deficiency: results from a single center 35
THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS AFFECTED BY PRIMARY IMMUNE THROMBOCYTOPENIA: ANALYSIS OF POSSIBLE PREDICTIVE FACTORS FOR SUSTAINED AND DURABLE RESPONSE FROM A RETROSPECTIVE CASE SERIES 35
Different regimens of prophylaxis treatment in young severe hemophilia A patients: comparisons on efficacy, FVIII consumption, and therapy compliance 34
Congenital FXI Deficiency: Preliminary Results Of Phenotypic (Clinical And Laboratory) And Genotypic Characterization Of A Case Series From A Single Center 34
Inhibitors in Hemophilia (HA): experience of a single center in the last 22 years 34
Prophylaxis treatment in young severe hemophilia A patients: efficacy, FVIII consumption, trough FVIII levels and therapy compliance 32
null 32
Inhibitors in Haemophilia A: Experience of A Single Center in The Last 20 Years 31
Pain assessment and management in Italian Haemophilia Centres 30
Efficacy and safety of antithrombotic prophylactic therapy with low-molecular-weight heparin (LMWH) after orthopaedic surgery in haemophilia patients 25
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort 24
Life-Threatening Autoimmune Hemolytic Anemia and Idhiopatic Thrombocytopenic Purpura. Successful Selective Splenic Artery Embolization 20
Prevention of dental injuries and management of first-aid procedures in hemophilia A (HA) children: experience of a single center 20
null 18
Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experience 18
Severe Thrombotic Complications in Congenital Afibrinogenemia: A Pathophysiological and Management Dilemma 17
The role of an accurate diagnosis of inherited thrombocytopenia as the basis for an effective treatment. A case of MYH9 syndrome treated with a TPO-RA 16
Tapentadol PR for pain syndromes in real life patients with hematological malignancy. 15
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center Cohort 15
Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up 14
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomised trial 13
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia 12
null 9
Totale 2.051
Categoria #
all - tutte 6.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 0 0 0 31 27 36 38 40 6
2020/2021124 14 15 5 5 3 20 5 13 12 18 12 2
2021/2022367 17 16 29 6 48 37 8 28 24 34 46 74
2022/2023501 81 149 26 60 42 46 13 28 47 0 8 1
2023/2024201 15 37 4 17 21 33 0 0 3 25 31 15
2024/2025330 17 91 34 55 64 67 2 0 0 0 0 0
Totale 2.051